• 1
    Hawkey PM, Jones AM. The changing epidemiology of resistance. J Antimicrob Chemother 2009; 64(Suppl 1): i3i10.
  • 2
    Leverstein-van Hall MA, Dierikx CM, Cohen Stuart J et al. Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains. Clin Microbiol Infect 2011; 17: 873880.
  • 3
    Overdevest I, Willemsen I, Rijnsburger M et al. Extended-spectrum β-lactamase genes of Escherichia coli in chicken meat and humans, the Netherlands. Emerg Infect Dis 2011; 17: 12161222.
  • 4
    Vinué L, Sáenz Y, Martínez S et al. Prevalence and diversity of extended-spectrum β-lactamases in faecal Escherichia coli isolates from healthy humans in Spain. Clin Microbiol Infect 2009; 15: 954956.
  • 5
    Geser N, Stephan R, Korczak BM, Beutin L, Hächler H. Molecular identification of extended-spectrum-β-lactamase genes from Enterobacteriaceae isolated from healthy human carriers in Switzerland. Antimicrob Agents Chemother 2012; 56: 16091612.
  • 6
    EFSA (European Food Safety Authority). Scientific opinion on the public health risks of bacterial strains producing extended-spectrum β-lactamases and/or AmpC β-lactamases in food and food-producing animals. EFSA J 2011; 9: 190.
  • 7
    Dierikx CM, van Essen-Zandbergen A, Veldman K, Smith H, Mevius D. Increased detection of extended-spectrum β-lactamase producing Salmonella enterica and Escherichia coli isolates from poultry. Vet Microbiol 2010; 145: 273278.
  • 8
    Hartmann A, Locatelli A, Amoureux L et al. Occurrence of CTX-M producing Escherichia coli in soils, cattle, and farm environment in France (Burgundy region). Front Microbiol 2012; 3: 83.
  • 9
    Dierikx CM, van Duijkeren E, Schoormans A et al. Occurrence and characteristics of extended-spectrum-β-lactamase-and AmpC-producing clinical isolates derived from companion animals and horses. J Antimicrob Chemother 2012; 67: 13681374.
  • 10
    Smet A, Martel A, Persoons D et al. Comparative analysis of extended-spectrum β-lactamase-carrying plasmids from different members of Enterobacteriaceae isolated from poultry, pigs and humans: evidence for a shared β-lactam resistance gene pool? J Antimicrob Chemother 2009; 63: 12861288.
  • 11
    Smet A, Rasschaert G, Martel A et al. In situ ESBL conjugation from avian to human Escherichia coli during cefotaxime administration. J Appl Microbiol 2011; 110: 541549.
  • 12
    Dierikx CM, Van der Goot J, Fabri T, van Essen-Zandbergen A, Smith H, Mevius D. Extended-spectrum-β-lactamase- and AmpC-β-lactamase-producing Escherichia coli in Dutch broilers and broiler farmers. J Antimicrob Chemother 2012; 68: 6067.
  • 13
    Thrusfield M, Ortega C, De Blas I, Noordhuizen JP, Frankena K. Win episcope 2.0: improved epidemiological software for veterinary medicine. Vet Rec 2001; 148: 567572.
  • 14
    Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 21st Informational Supplement M100-21. Wayne, PA: CLSI, 2011.
  • 15
    Hosmer DW, Lemeshow S. Applied logistic regression, 2nd edn. Hoboken, New Jersey: John Wiley & Sons, Inc., 2000.
  • 16
    Tängdén T, Cars O, Melhus Å, Löwdin E. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum β-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother 2010; 54: 35643568.
  • 17
    Ben-Ami R, Rodríguez-Baño J, Arslan H et al. A multinational survey of risk factors for infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in nonhospitalized patients. Clin Infect Dis 2009; 49: 682690.
  • 18
    Ben Sallem R, Ben Slama K, Estepa V et al. Prevalence and characterisation of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolates in healthy volunteers in Tunisia. Eur J Clin Microbiol Infect Dis 2012; 31: 15111516.
  • 19
    Luvsansharav UO, Hirai I, Niki M et al. Prevalence of fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae among healthy adult people in Japan. J Infect Chemother 2011; 17: 722725.